Live feed
Filing
SC 13G
SC 13G0001493152-20-021030·Damora Therapeutics, Inc.
Schedule 13G ownership disclosure
GALECTO INC
Security class unavailable · CUSIP: 36322Q107
Event date: 2020-11-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 3.5100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-20-021030
- Form type
- SC 13G
- Filer
- Damora Therapeutics, Inc.
- CIK
- CIK 1800315
- Filed
- Nov 12, 2020
- Reporting period
- Nov 02, 2020
- Description
- Schedule 13G beneficial ownership